Literature DB >> 23409817

What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis?

Shyam Sundar, Anup Singh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23409817     DOI: 10.1586/eri.12.170

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  7 in total

1.  Elimination of Kala-Azar from the Southeast Asia Region.

Authors:  Sujit K Bhattacharya; Aditya Prasad Dash
Journal:  Am J Trop Med Hyg       Date:  2017-01-23       Impact factor: 2.345

Review 2.  Elimination of visceral leishmaniasis on the Indian subcontinent.

Authors:  Om Prakash Singh; Epco Hasker; Marleen Boelaert; Shyam Sundar
Journal:  Lancet Infect Dis       Date:  2016-09-28       Impact factor: 25.071

Review 3.  Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  Front Immunol       Date:  2014-06-26       Impact factor: 7.561

Review 4.  Vaccines to prevent leishmaniasis.

Authors:  Rajiv Kumar; Christian Engwerda
Journal:  Clin Transl Immunology       Date:  2014-03-14

Review 5.  Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.

Authors:  Nicky Didwania; Md Shadab; Abdus Sabur; Nahid Ali
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

6.  Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis.

Authors:  Saptarshi Roy; Devawati Dutta; Eswara M Satyavarapu; Pawan K Yadav; Chhabinath Mandal; Susanta Kar; Chitra Mandal
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

Review 7.  The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics.

Authors:  Rubem Figueiredo Sadok Menna-Barreto; Solange Lisboa de Castro
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.